KOAH Bülteni 2013 Sayı 2

derleme
nary disease in 2010. Am J Respir Crit Care Med
2011;183(10):1311–5.
26. Pillai SG, Ge D, Zhu G, et al. A genome-wide association
study in chronic obstructive pulmonary
disease (COPD): identification of two major susceptibility
loci. PLoS Genet 2009;5(3):e1000421.
27. Guerra S. Overlap of asthma and chronic obstructive
pulmonary disease. Curr Opin Pulm Med
2005;11(1):7–13.
28. Sin DD, Cohen SB, Day A, et al. Understanding the
biological differences in susceptibility to chronic
obstructive pulmonary disease between men and
women. Proc Am Thorac Soc 2007;4(8):671–4.
29. Vogelmeier CF, Wouters EF. Treating the systemic
effects of chronic obstructive pulmonary disease.
Proc Am Thorac Soc 2011;8(4):376–9.
30. Lee SD, Ju G, Choi JA, et al. The association of
oxidative stress with central obesity in obstructive
sleep apnea. Sleep Breath 2011.
31. Lee R, McNicholas WT. Obstructive sleep apnea in
chronic obstructive pulmonary disease patients.
Curr Opin Pulm Med 2011;17(2):79–83.
32. Spurzem JR, Rennard SI. Pathogenesis of COPD.
Semin Respir Crit Care Med 2005;26(2):142–53.
33. Hogg JC, Chu F, Utokaparch S, et al. The nature
of small-airway obstruction in chronic
obstructive pulmonary disease. N Engl J Med
2004;350(26):2645–53.
34. Kirkham P, Rahman I. Oxidative stress in asthma
and COPD: antioxidants as a therapeutic strategy.
Pharmacol Ther 2006;111(2):476–94.
35. Gosselink JV, Hayashi S, Elliott WM, et al. Differential
expression of tissue repair genes in
the pathogenesis of chronic obstructive pulmonary
disease. Am J Respir Crit Care Med
2010;181(12):1329–35.
36. Mannino DM, Valvi D, Mullerova H, Tal-Singer R.
Fibrinogen, COPD and mortality in a nationally
representative U.S. cohort. COPD 2012; 9:359–
366.
37. Miniati M, Monti S, Bottai M, et al. Prognostic
value of C-reactive protein in chronic obstructive
pulmonary disease. Intern EmergMed 2011;
6:423–430
38. Cowburn AS, Condliffe AM, Farahi N, et al. Advances
in neutrophil biology: clinical implications.
Chest 2008; 134:606–61.
39. Nicholas BL, O’Connor CD, Djukanovic R. From
proteomics to prescription –the search for COPD
biomarkers. COPD 2009; 6:298–303.
40. Nicholas BL. Search for biomarkers in chronic
obstructive pulmonary disease: current status.
Curr Opin Pulm Med. 2013;19(2):103-8.
41. Braber S, Thio M, Blokhuis BR, et al. An association
between neutrophils and immunoglobulin free
light chains in the pathogenesis of chronic obstructive
pulmonary disease. Am J Respir Crit Care
Med 2012; 185:817–824.
42. Bonarius HP, Brandsma CA, Kerstjens HA, et al.
Antinuclear autoantibodies are more prevalent in
COPD in association with low body mass index but
not with smoking history. Thorax 2011; 66:101–
107.
43. Stanojkovic I, Kotur-Stevuljevic J, Milenkovic B, et
al. Pulmonary function, oxidative stress and inflammatory
markers in severe COPD exacerbation.
Respir Med 2011; 105 (Suppl. 1):S31–S37.
44. Cappello F, Caramori G, Campanella C, et al.
Convergent sets of data from in vivo and in vitro
methods point to an active role of Hsp60 in chronic
obstructive pulmonary disease pathogenesis.
PLoS One 2011; 6:e28200.
45. Lindberg CA, Engstrom G, de Verdier MG, et al. Total
desmosines in plasma and urine correlate with
lung function. Eur Respir J 2012; 39:839–845.
46. Carter RI, Mumford RA, Treonze KM, et al. The fibrinogen
cleavage product Aalpha-Val360, a specific
marker of neutrophil elastase activity in vivo.
Thorax 2011; 66:686–691.
47. Jouneau S, Khorasani N, DE Souza P, et al. EM-
MPRIN (CD147) regulation of MMP-9 in bronchial
epithelial cells in COPD. Respirology 2011;
16:705–712.
48. Stocks J, Sonnappa S. Early life influences on the
development of chronic obstructive pulmonary disease.
Ther Adv Respir Dis. 2013 Jun;7(3):161-73.
49. Bush A. COPD: a pediatric disease. COPD.
2008;5(1):53-67.
50. Didon L, Roos AB, Elmberger GP, et al. Lung-specific
inactivation of CCAAT/enhancer binding protein
alpha causes a pathological pattern characteristic
of COPD. Eur Respir J. 2010;35(1):186-97.
51. Narang I, Bush A. Early origins of chronic obstructive
pulmonary disease. Semin Fetal Neonatal
Med. 2012;17(2):112-8.
52. Dharmage SC, Erbas B, Jarvis D, et al. Do childhood
respiratory infections continue to influence
adult respiratory morbidity? Eur Respir J.
2009;33(2):237-44.
53. Svanes C, Sunyer J, Plana E, et al. Early life origins
of chronic obstructive pulmonary disease.
Thorax. 2010;65(1):14-20.
54. Gold DR, Tager IB, Weiss ST, et al. Acute lower
respiratory illness in childhood as a predictor of
lung function and chronic respiratory symptoms.
Am Rev Respir Dis. 1989;140(4):877-84.
55. Johnston ID, Strachan DP, Anderson HR. Effect
of pneumonia and whooping cough in childhood
on adult lung function. N Engl J Med.
1998;338(9):581-7.
56. Castro-Rodríguez JA, Holberg CJ, Wright AL,
Association of radiologically ascertained pneumonia
before age 3 yr with asthmalike symptoms
and pulmonary function during childhood:
a prospective study. Am J Respir Crit Care Med.
1999;159(6):1891-7.
12